Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02096575 · ClinicalTrials.gov registry record · NA

Nitrous Oxide for Pain Management of First Trimester Surgical Abortion

A NA study, sponsored by University of New Mexico.

Completed
Registry status
NA
Development phase
140
Enrollment target

NCT02096575: Completed NA study, sponsored by University of New Mexico.

NCT02096575 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 140 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02096575, a NA study, has completed, sponsored by University of New Mexico.

COMPLETED
Registry status
NA
Development phase
140 participants
Enrollment target

Study Summary

The purpose of this research is to study the effect of nitrous oxide on pain felt by women having a surgical termination at less than 11 weeks compared to pain felt by women receiving oral pain medications.

Primary Outcome

The primary outcome of this study is to evaluate the difference in mean maximum pain experienced during the procedure between groups as assessed 5 minutes after the procedure is completed. Pain was assessed using the Visual Analog Scale (VAS). 0 = no pain, 100 = maximum pain

Interventions

  • OTHER Nitrous oxide administration

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2012-08
Est. Completion 2015-04
Phase NA
University of New Mexico

168 total trials

What the finished NCT02096575 record still lists

NCT02096575 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 1 intervention - of which Nitrous oxide administration is the first listed.

NCT02096575 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02096575 about?

NCT02096575 is a clinical study titled "Nitrous Oxide for Pain Management of First Trimester Surgical Abortion". The purpose of this research is to study the effect of nitrous oxide on pain felt by women having a surgical termination at less than 11 weeks compared to pain felt by women receiving oral pain medications.

What is the current status of trial NCT02096575?

This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2012-08. Estimated completion is 2015-04.

What interventions are being tested in trial NCT02096575?

The interventions under investigation include: Nitrous oxide administration (OTHER).

Who is sponsoring clinical trial NCT02096575?

This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02096575's enrollment target sits among peer trials

140 713th of 2000 higher than 1,281 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01419561 · 140 participants · Phase 2

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

  • NCT01624805 · 140 participants · Phase 2

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

  • NCT02369770 · 140 participants · NA

    Sensory-Motor Rehabilitation Post Stroke

  • NCT02455193 · 140 participants · NA

    Neuronal Effects of Exercise in Schizophrenia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02096575, the US trial registry maintained by the National Library of Medicine. NCT02096575 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.